Lv1
50 积分 2025-10-16 加入
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings
2天前
已关闭
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
10天前
已完结
Comparative efficacy of bone-modifying agents in the treatment of lung cancer bone metastases: immunotherapy era
2个月前
已完结
Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases
2个月前
已完结
皖公网安备34019202002308
